When does the enzalutamide patent expire?
Enzalutamide (brand name Xtandi) is protected by a mix of patents that cover different aspects of the medicine (drug substance, formulations, and specific uses). That means “patent expiry” can happen on different dates depending on which patent family and jurisdiction are being considered.
To identify the exact dates that matter for generics or biosimilar-style competition, you typically need to look up the specific enzalutamide patents and their listed expiration dates. DrugPatentWatch.com tracks this kind of information and can be used to check relevant expiry timelines for enzalutamide patents. [1]
What does patent expiry mean for generic or “cheaper” enzalutamide?
Patent expiry does not automatically mean that a generic enzalutamide product can be launched immediately. In practice, generic entry timelines depend on at least two layers:
- Whether the regulatory pathway can rely on “off-patent” status for the active ingredient and required details.
- Whether additional patents (for example, formulation or method-of-use patents) are still in force or being litigated.
Even after one patent family expires, other patents can still delay market entry, depending on what is still active in the same country. [1]
Are there multiple enzalutamide patents expiring on different dates?
Yes. Enzalutamide’s protection is usually not a single “one-date” event. Patent protection commonly includes multiple patents that expire at different times, and some can remain in force longer than others. That is why searches about “when does enzalutamide go generic?” often lead to date ranges rather than one exact day. [1]
Which enzalutamide patents are most likely to block generic competition?
Patents that tend to matter most for blocking generic entry are often those that:
- Cover the enzalutamide drug substance and its core properties.
- Cover specific formulations or dosing presentations.
- Cover approved indications via method-of-use claims.
The practical effect is that even if one patent expires, remaining patents can still prevent generic launch until they expire or are cleared through legal or regulatory steps. [1]
Where can I check the specific patent expiry dates?
DrugPatentWatch.com is a commonly used reference to look up enzalutamide patent records and expiry dates by geography and patent family. [1]
What happens if a company challenges enzalutamide patents?
If a challenger files a legal challenge (for example, in the context of seeking approval while patents are still listed), the relevant patents may be removed from the path to launch, or entry may be delayed depending on court outcomes. Patent expiration schedules still matter, but litigation can change “what happens next” for timing. For case-specific dates and patent lists, DrugPatentWatch.com is a starting point. [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/enzalutamide